Pratt Collard Advisory Partners’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-2,675
Closed -$201K 113
2017
Q4
$201K Buy
+2,675
New +$202K 0.17% 110

Other funds holding NVS

Pratt Collard Advisory Partners's NVS Position: Q1 2018 in Review

Pratt Collard Advisory Partners sold out of Novartis (NVS) in Q1 2018, closing a stake of 2,675 shares — an estimated $201K sold.

Pratt Collard Advisory Partners first reported a position in NVS in Q4 2017 and held it in 1 quarter. The position peaked at $201K in Q4 2017. 1,012 funds tracked by Wall St. Rank hold NVS as of Q1 2018.

  • Pratt Collard Advisory Partners reported no remaining Novartis position as of Q1 2018 after selling out during the quarter.
  • Pratt Collard Advisory Partners sold 2,675 Novartis shares in Q1 2018, an estimated $201K.
  • Pratt Collard Advisory Partners first reported a position in Novartis in Q4 2017 and held it in 1 quarter.
  • Pratt Collard Advisory Partners's Novartis position peaked at $201K in Q4 2017.
  • 1,012 funds tracked by Wall St. Rank held Novartis as of Q1 2018.

Based on Pratt Collard Advisory Partners's 13F filing for Q1 2018, filed 20 Apr 2018.